HAEHaemonetics CorporationHealthcare · Medical - Devicesas of 2026-09-16
Horizon

Issued 2026-09-16 at $106.24 · now $106.24 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, HAE has typically landed between $89.44 and $126.20 — a range of −15.8% to +18.8% from the issuance price $106.24.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

5,003 overlapping 1 month windows · 2006-09-26 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($106.24) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where HAE has typically landed a month from the 2026-09-16 close of $106.24 — the range is history, not a prediction.

$89.44worst · -15.8%$126.2best · +18.8%
  • now $106.24 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $107.16 (+0.9%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $99.83–$114.49
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $89.44–$126.2
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 5,003 windows spanning 2006-09-26 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2021-04-14−55.7%−55.7%+1.4%
2021-04-15−52.8%−56.3%+0.0%
2021-04-16−51.3%−55.7%+0.0%
3 best
2025-11-04+66.4%+0.0%+66.4%
2025-11-05+65.5%+0.0%+65.5%
2025-10-29+64.5%+0.0%+64.5%

5,003 overlapping windows · 2006-09-26 – 2026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~20 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
40%
−1.8%
n=20
Feb
40%
−0.5%
n=20
Mar
75%
+1.9%
n=20
Apr
50%
−2.5%
n=20
May
55%
+2.1%
n=20
Jun
65%
+3.1%
n=20
Jul
70%
+2.5%
n=20
Aug
60%
+0.7%
n=20
Sep
45%
+0.6%
n=20
Oct
50%
+0.1%
n=20
Nov
55%
+6.2%
n=20
Dec
55%
+0.4%
n=20

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$109$482025-11-10: 1 insider purchase, $99K — KROLL MARK W2025-11: 1 open-market purchase, $99K↑ buys↓ salesdirector KROLL MARK W — Purchase on 2025-11-10, filed 2 days after the trade
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2025-11-10KROLL MARK WdirectorPurchase1,400 @ $70.56$99K+6.0% of holding+22.8%−28.7%24,757Form 4 · filed 2 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

104 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-07-24Bryant Diane MdirectorAward / grant2,5389,664Form 4
2026-07-24COYLE MICHAEL JdirectorAward / grant2,53817,932Form 4
2026-07-24ABERNATHY ROBERT EdirectorAward / grant2,53827,519Form 4
2026-07-24Bryant Diane MdirectorAward / grant2,5389,664Form 4
2026-07-24COYLE MICHAEL JdirectorAward / grant2,53817,932Form 4
2026-07-24Johnson Lloyd EmersondirectorAward / grant2,53815,471Form 4
2026-07-24KROLL MARK WdirectorAward / grant2,53827,295Form 4
2026-07-24Pomeroy ClairedirectorAward / grant2,53819,410Form 4
2026-07-24Zane Ellen MdirectorAward / grant2,53821,911Form 4
2026-07-24ABERNATHY ROBERT EdirectorAward / grant2,53827,519Form 4
2026-07-24Madaus Martin DdirectorAward / grant2,5382,538Form 4
2026-07-24Johnson Lloyd EmersondirectorAward / grant2,53815,471Form 4
2026-07-24KROLL MARK WdirectorAward / grant2,53827,295Form 4
2026-07-24Madaus Martin DdirectorAward / grant2,5382,538Form 4
2026-07-24Pomeroy ClairedirectorAward / grant2,53819,410Form 4
2026-07-24Zane Ellen MdirectorAward / grant2,53821,911Form 4
2026-06-05Miller Laurie A.officerWithheld for tax31340,987Form 4
2026-06-05Maunsell Farris MaryanneofficerWithheld for tax2596,242Form 4
2026-05-15Simon, ChristopherdirectorWithheld for tax9,681366,360Form 4
2026-05-15Basil Michelle LofficerWithheld for tax2,91340,405Form 4
2026-05-15DArecca JamesdirectorWithheld for tax2,50525,132Form 4
2026-05-15Miller Laurie A.officerWithheld for tax94827,977Form 4
2026-05-15Galvin RoyofficerWithheld for tax87912,347Form 4
2026-05-15Chan FrankofficerWithheld for tax5465,401Form 4
2026-05-15Maunsell Farris MaryanneofficerWithheld for tax1974,281Form 4
2026-05-15Simon, ChristopherdirectorAward / grant78,344444,704Form 4
2026-05-15Galvin RoyofficerAward / grant27,53539,882Form 4
2026-05-15Maunsell Farris MaryanneofficerAward / grant2,2206,501Form 4
2026-05-15Miller Laurie A.officerAward / grant13,32341,300Form 4
2026-05-15Galvin RoyofficerAward / grant27,53539,882Form 4
2026-05-15Maunsell Farris MaryanneofficerAward / grant2,2206,501Form 4
2026-05-15Miller Laurie A.officerAward / grant13,32341,300Form 4
2026-05-15DArecca JamesdirectorAward / grant29,31254,444Form 4
2026-05-15DArecca JamesdirectorAward / grant29,31254,444Form 4
2026-05-15Basil Michelle LofficerAward / grant28,42468,829Form 4
2026-05-15Chan FrankofficerAward / grant27,53532,936Form 4
2026-05-15Basil Michelle LofficerAward / grant28,42468,829Form 4
2026-05-15Simon, ChristopherdirectorAward / grant78,344444,704Form 4
2026-05-15Chan FrankofficerAward / grant27,53532,936Form 4
2026-05-01DArecca JamesdirectorWithheld for tax65527,637Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.